Clinical Trials Browser

INDUSTRY × Neoplasms × Nadroparin × Clear all

NCT00951574 2012-02-01

Prevention of Venous and Arterial Thromboembolism, in Cancer Patients Undergoing Chemotherapy, With a Low Molecular Weight Heparin (Nadroparin Calcium)

Phase 3 Completed

Neoplasm Metastasis, Neoplasms, Thromboembolism